{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:04Z","timestamp":1786996324827,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.rmed.2018.03.035","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T23:22:59Z","timestamp":1522970579000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"138","author":[{"given":"Nafiseh","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Assayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Mohammad-Yousof","family":"Mostafavi-Pour-Manshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Kaddaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bourbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2018.03.035_bib1","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.rmed.2012.12.019","article-title":"Preventing COPD exacerbations with macrolides: a review and budget impact analysis","volume":"107","author":"Simoens","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970-2002","volume":"294","author":"Jemal","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.rmed.2018.03.035_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.163.5.585","article-title":"Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sante du Q. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention","volume":"163","author":"Bourbeau","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","volume":"156","author":"Collet","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)","volume":"154","author":"Connors","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.03.035_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.164.3.2010017","article-title":"Lung Health Study Research G. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study","volume":"164","author":"Kanner","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.03.035_bib10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Evaluation of CLtIPSEI. Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4104\/pcrj.2013.00061","article-title":"Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study","volume":"22","author":"James","year":"2013","journal-title":"Prim. Care Respir. J. : J. Gen. Pract. Airways Group"},{"key":"10.1016\/j.rmed.2018.03.035_bib12","series-title":"From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2017"},{"key":"10.1016\/j.rmed.2018.03.035_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2018.03.035_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-14-125","article-title":"Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial","volume":"14","author":"Berkhof","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2018.03.035_bib15","first-page":"3s","article-title":"Sputum induction","volume":"37","author":"Paggiaro","year":"2002","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.rmed.2018.03.035_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.rmed.2018.03.035_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12952-015-0034-8","article-title":"A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Shafuddin","year":"2015","journal-title":"J. Negat. Results Biomed."},{"key":"10.1016\/j.rmed.2018.03.035_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.rmed.2013.02.009","article-title":"Role of long term antibiotics in chronic respiratory diseases","volume":"107","author":"Suresh Babu","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/thorax.57.3.189","article-title":"Macrolide antibiotics and cystic fibrosis","volume":"57","author":"Peckham","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.03.035_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thx.2007.092858","article-title":"Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation","volume":"63","author":"Terada","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.03.035_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.2007.146134","article-title":"Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis","volume":"57","author":"Blondeau","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.rmed.2018.03.035_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-009-0725-4","article-title":"Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients","volume":"54","author":"Mertens","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.rmed.2018.03.035_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2018.03.035_bib24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.rmed.2018.03.035_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkh309","article-title":"Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis","volume":"54","author":"Schultz","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rmed.2018.03.035_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.03.035_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib29","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.201402-0207OC","article-title":"Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy","volume":"189","author":"Han","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.03.035_bib31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1532-5415.2008.01725.x","article-title":"Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis","volume":"56","author":"Yamaya","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.rmed.2018.03.035_bib32","first-page":"1697","article-title":"Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trial","volume":"13","author":"Burr","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2018.03.035_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118301070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118301070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:41:38Z","timestamp":1760614898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611118301070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"alternative-id":["S0954611118301070"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2018.03.035","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2018.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}